Ab Index-Nr. 611-138-00-1

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
611-138-00-12-(4-aminophenyl)-6-tert-
butyl-1H-pyrazolo
[1,5-b][1,2,4]triazole
415-910-7152828-25-6Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
611-139-00-7reaction product of:
C.I. Leuco Sulfur
Black 1 with (3-chloro-2-
hydroxypropyl)trimethylam-
monium chloride
424-510-1Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
611-140-00-2azafenidin (ISO);
2-(2,4-dichloro-5-prop-2-
ynyloxyphenyl)-
5,6,7,8-tetrahydro-1,2,4-
triazolo[4,3-a]pyri-
din-3(2H)-one
68049-83-2Repr. 1B
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H373 (*)(*)
H400
H410
GHS08
GHS09
Dgr
H360Df
H373 (*)(*)
H410
 M = 1000 
611-141-00-85-(4-[4-[4-(3,5-dicarboxy-
phenylazo)phenylamino]-6-
morpholin-4-yl-1,3,5-triazin-2-
ylamino]phenylazo)iso-
phthalic acid,
mixed monosodium and diammonium salt
414-410-6Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
611-142-00-3product-by-process definition polyazodyestuff obtained by coupling
4-[4-(1-amino-8-hydroxy-3,6-
disulfo-2-naphthylazo)phenyl-
sulfonylamino]benzenediazo-
nium with reaction
mass of 4-carboxybenze-
nediazonium and diphenylamine-3-sulfo-4,4´-
bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-amino-
phenol, sodium salts;
sodium chloride
425-740-5Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
611-143-00-9reaction mass of: trisodium
2-(2-[α-(2-carboxylato-
κ-O-4-sulfonato-
phenylazo)benzylidene]
hydrazino-κ-N´)-6-(2,6-
difluoropyrimidin-4-ylamino)-4-
sulfonatophenolatocuprate (II);
trisodium 2-(2-[α-(2-
carboxylato-κ-O-4-
sulfonatophenylazo)benzy-
lidene]hydrazino-κ-N´)-6-
(4,6-difluoropyrimidin-2-
ylamino)-4-sulfonato-
phenolatocuprate (II)
428-260-4Eye Dam. 1H318GHS05
Dgr
H318   
611-144-00-4reaction mass of:
7-amino-3,8-bis-[4-(2-
sulfoxyethylsulfonyl)phe-
nylazo]-4-hydroxy-
naphthalene-2-
sulfonic acid, Na/K salt;
7-amino-3-[4-(2-sulfoxyethyl-
sulfonyl)phenylazo]-4-
hydroxy-8-[4-(2-
sulfoxyethylsulfonyl)-2-
sulfophenylazo]naphthalene-2-
sulfonic acid, Na/K salt;
7-amino-8-[4-(2-sulfoxy-
ethylsulfonyl)-phenylazo]-4-
hydroxy-3-[4-(2-
sulfoxyethylsulfonyl)-2-
sulfophenylazo]naphthalene-2-
sulfonic acid, Na/K salt;
7-amino-3,8-bis-[4-(2-
sulfoxyethylsulfonyl)-2-
sulfophenylazo]-4-
hydroxynaphthalene-2-sulfonic acid, Na/K salt
429-070-4214362-06-8Eye Dam. 1H318GHS05
Dgr
H318   
611-145-00-Xreaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-
2-ylazo)-4-hydroxy-7-{4-
chloro-6-[4-(2-sulfoxyethyl-
sulfonyl)phenylamino]-
1,3,5-triazine-2-
ylamino}naphthalene-2-
sulfonate;
3-(2,5-disulfophenylazo)-4-
hydroxy-7-{4-chloro-6-[4-(2-
sulfoxyethylsulfonyl)phenyl-
amino]-1,3,5-triazine-2-
ylamino}naphthalene-2-sulfonic acid,
sodium salt
429-440-5Eye Dam. 1H318GHS05
Dgr
H318   
611-146-00-5reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-
sulfonato-3-(4-sulfonato-
phenylazo)phenylazo)-1-
hydroxy-3-sulfonatonaph-
thalen-2-ylazo)-2-sulfonato-
phenylamino)phenylazo)-4-
hydroxy-6-(2-oxo-1-
phenylcarbamoylpropylazo)
naphthalene-2-sulfonate;
pentasodium 6-((2,4-diamino-5-
sulfonatophenyl)azo)-3-((4-
((4-((7-((2,4-diamino-5-
sulfonatophenyl)azo)-1-
hydroxy-3-sulfonatonaph-
thalen-2-yl)azo)phenyl)amino)-
2-sulfonatophenyl)azo)-4-
hydroxynaphthalene-2-
sulfonate;
pentasodium 6-((2,4-diamino-
5-sulfonato-3-((4-sulfonato-
phenyl)azo)phenyl)azo)-3-
((4-((4-((1,7-dihydroxy-3-
sulfonatonaphthalen-2-yl)azo)-
2-sulfonatophenyl)ami-
no)phenyl)azo)-4-hydroxy-
naphthalene-2-sulfonate;
hexasodium 6-((2,4-diamino-5-
sulfonatophenyl)azo)-3-((4-((4-
((7-((2,4-diamino-5-sulfonato-3-
((4-sulfonatophenyl)azo)phe-
nyl)azo)-1-hydroxy-3-sulfo-
natonaphthalen-2-yl)azo)-2-
sulfonatophenyl)amino)phe-
nyl)azo)-4-hydroxynaphthale-
ne-2-sulfonate
430-070-1Aquatic Chronic 2H411GHS09H411   
611-147-00-0sodium, potassium, lithium
5-amino-3,6-bis(5-(4-chloro-6-
(methyl-(2-methylamino-
acetyl)amino)-1,3,5-triazin-2-
ylamino)-2-sulfonato-
phenylazo)-4-hydroxy-
naphthalene-2,7-disulfonate
430-090-0205764-96-1Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
611-148-00-6reaction mass of:
2-(3-(2,6-dichloro-
4-nitrophenylazo)carbazol-9-
yl)ethanol;
2-(2-(3-(2,6-dichloro-4-nitro-
phenylazo)-carbazol-9-yl)-
ethoxy)ethanol;
3-(2,6-dichloro-4-
nitrophenylazo)carbazol
429-590-1Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
611-149-00-12-(2-chloroacetoxy)ethyl
3-((4-(2,5-dichloro-4-fluoro-
sulfonylphenylazo)-
3-methylphenyl)ethylamino)
propionate
427-570-7193486-83-8Aquatic Chronic 2H411GHS09H411   
611-150-00-7tetralithium 2-[6-[7-[2-
(carboxylato)phenylazo]-8-
hydroxy-3,6-disulfonato-1-
naphthylamino]-4-
hydroxy-1,3,5-triazine-2-
ylamino]benzoate
440-460-3Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
   
611-151-00-2chrysoidine;
4-(phenylazo)benzene-1,3-
diamine
207-803-7495-54-5Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H341
H302
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H302
H315
H410
   
611-152-00-8chrysoidine monohydrochloride;
4-phenylazophenylene-
1,3-diamine
monohydrochloride; [1]
chrysoidine monoacetate;
4-(phenylazo)benzene-
1,3-diaminemonoacetate; [2]
chrysoidine acetate;
4-(phenylazo)benzene-1,3-
diamineacetate; [3]
chrysoidine-p-
dodecylbenzenesulfonate;
dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-
1,3-diamine (1:1); [4]
chrysoidine dihydrochloride;
4-(phenylazo)benzene-1,3-
diaminedihydrochloride; [5]
chrysoidine sulfate;
bis[4-(phenylazo)benzene-1,3-
diamine] sulfate [6]
208-545-8 [1]
278-290-5 [2]
279-116-0 [3]
264-409-8 [4]
281-549-5 [5]
282-432-1 [6]
532-82-1 [1]
75660-25-2 [2]
79234-33-6 [3]
63681-54-9 [4]
83968-67-6 [5]
84196-22-5 [6]
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H302
H315
H318
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H341
H302
H315
H318
H410
   
611-153-00-3chrysoidine C10-14-alkyl derivatives;
benzenesulfonic acid, mono-C10-14-
alkyl derivatives, compounds with 4-(phenylazo)-1,3-
benzenediamine; [1]
chrysoidine compound with dibutylnaphthalene sulfonic acid;
dibutylnaphthalenesulfonic acid,
compound with 4-(phenylazo)benzene-1,3-
diamine(1:1) [2]
286-946-7 [1]
304-236-8 [2]
85407-90-5 [1]
94247-67-3 [2]
Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
H341
H302
H315
H318
GHS05
GHS08
GHS07
Dgr
H341
H302
H315
H318
   
611-154-00-9trisodium 5-benzamido-
4-hydroxy-3-(4-methyl-2-
sulfonatophenylazo)
naphthalene-2,7-disulfonate
403-670-692408-46-3Aquatic Chronic 3H412H412   
611-155-00-44,4´-oxybis(benzene-
sulfonylazide)
431-850-47456-68-0Expl. 1.1****
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H201
H373 **
H400
H410
GHS01
GHS08
GHS09
Dgr
H201
H373 **
H410
   
611-156-00-Xtriammonium
4-[4-[7-(4-carboxylatoanilino)-1-
hydroxy-3-sulfonato-2-
naphthylazo]-2,5-dimethoxy-
phenylazo]benzoate
432-270-4221354-37-6Repr. 2
STOT RE 2 *
Aquatic Chronic 2
H361f ***
H373 **
H411
GHS08
GHS09
Wng
H361f ***
H373 **
H411
   
611-157-00-5benzenesulfonic acid, 3,3´-
(methylenebis((dihydroxy-
phenylene)
azo))bis-, potassium sodium salt;
potassium sodium 3-[(E)-(6-{3,4-
dihydroxy-2-[(Z)-(3-
sulfonatophenyl)diazenyl]ben-
zyl}-2,3-dihydroxyphenyl)di-
azenyl]benzenesulfonate
432-590-4243869-48-9Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
   
611-158-00-0reaction product of:
2,3,4,2´,3´,4´-
hexahydroxy-5,5´-diacethyl-
diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-
naphthalenesulfonylchloride and
3-diazo-3,4-dihydro-6-
methoxy-4-oxo-1-
naphthalenesulfonylchloride
421-520-8****
Aquatic Chronic 4
****
H413
********
H413
   
611-159-00-6disodium 4-amino-6-((4-((4-(2,4-
diaminophenyl)azo)phenyl-
sulfamoyl)phenyl)azo)-5-
hydroxy-3-((4-nitro-
phenyl)azo)naphthalene-2,7-
disulfonate
421-880-6Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
611-160-00-1reaction mass of:
1,1,1-tris(phenyl-
4´-(3´´-diazo-3´´,4´´-dihydro-4´´-
oxonaphthalene-1´´-
sulfonato)ethane;
1,1,1-tris(phenyl-4´-(6´´-
diazo-5´´,6´´-dihydro-5´´-oxo-
naphthalene-1´´-
sulfonato)ethane;
reaction product of 1,1,1-tris(p-
hydroxyphenyl)ethane with
6-diazo-5,6-dihydro-5-oxo-1-
naphthylsulfonylchloride and
3-diazo-3,4-dihydro-4-oxo-1-
naphthylsulfonylchloride (2:1);
reaction product of 1,1,1-tris(p-
hydroxyphenyl)ethane with
6-diazo-5,6-dihydro-5-oxo-1-
naphthylsulfonylchloride and
3-diazo-3,4-dihydro-4-oxo-1-
naphthylsulfonylchloride (1:2)
422-760-6****
Aquatic Chronic 4
****
H413
********
H413
   
611-161-00-7trisodium [1,2´-(2-(8-amino-3,5-
disulfonatonaphthalene)azo)-
(4´-nitrobenzene)diolato-
O,O,N][(Z)-2,2-((phenylcar-
bamoylprop-1´-enyl)azo)-5-
sulfamoylbenzene)
diolato-O,O,N]chromate(III)
423-100-1Eye Dam. 1H318GHS05
Dgr
H318   
611-162-00-22,4-bis(((2-(dimethylam-
monio)ethyloxy)carbonyl)phen-
2-ylazo)benzene-1,3-
diolbis(methanesulfonate)
429-600-4Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
   
611-163-00-82,4-bis(((2-(dimethylam-
monio)ethyloxy)carbonyl)phen-
2-ylazo)benzene-1,3-
diol sulfate
429-610-9Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
   
611-164-00-3reaction mass of:
2,2´-dimethyl-2,2´-
azobutanenitrile;
2-methylpentanenitrile-2-azo-2´-
(2´-methylpropanenitrile);
2,2´-dimethyl-2,2´-
azoheptanenitrile;
2-methylheptanenitrile-2-azo-2´-
(2´-methylpropanenitrile);
2-methylheptanenitrile-2-azo-2´-
(2´-methylbutanenitrile)
429-710-2Self-react. D
Acute Tox. 4 *
Aquatic Chronic 2
H242
H302
H411
GHS02
GHS07
GHS09
Dgr
H242
H302
H411
   
611-165-00-9reaction mass of: tetrasodium
4-amino-6-(5-(2,6-
difluoropyrimidin-4-ylamino)-2-
sulfonatophenylazo)-5-
hydroxy-3-(4-
(sulfatoethylsulfonyl)phenylazo)
naphthalene-2,7-disulfonate;
tetrasodium 4-amino-6-(5-(4,6-
difluoropyrimidin-2-ylamino)-2-
sulfonatophenylazo)-5-
hydroxy-3-(4-(2-sulfato-
ethylsulfonyl)phenylazo)
naphthalene-2,7-disulfonate
431-830-5Aquatic Chronic 3H412H412   
611-166-00-4reaction mass of: pentasodium
4-amino-5-hydroxy-3-{(E)-4-[2-
(sulfonatooxy)ethylsulfonyl]
phenylazo}-6-{(E)-2-sulfonato-
4-[2-(sulfonatooxy)ethylsulfonyl]
phenylazo}naphthalene-2,7-
disulfonate;
tetrasodium 4-amino-5-
hydroxy-3-{(E)-4-
[2-(sulfonatooxy)ethyl-
sulfonyl]phenylazo}-6-[(E)-2-
sulfonato-4-(vinylsulfonyl)phe-
nylazo]naphthalene-
2,7-disulfonate;
tetrasodium 4-amino-
5-hydroxy-6-{(E)-2-sulfonato-
4-[2-(sulfonatooxy)ethylsulfo-
nyl]phenylazo}-3-[(E)-4-
(vinylsulfonyl)phenylazo]
naphthalene-2,7-disulfonate
432-100-9Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
611-167-00-Xsodium bis[tris(2-hy-
droxyethyl)ammonium][6-
anilino-4´-(4,8-disulfonato-2-
naphthylazo)-5´-methyl-3-
sulfonatonaphthalene-2-
azobenzene-1,2´-
diolato]cuprate(II)
435-240-9Aquatic Chronic 3H412H412   
611-168-00-5reaction mass of: 3-[[4-chloro-
6-[[7-[(1,5-disulfo-2-
naphthalenyl)azo]-8-
hydroxy-3,6-disulfo-1-
naphthalenyl]amino]-1,3,5-
triazin-2-yl]amino]-5-[[4-
chloro-6-[[8-hydroxy-3,6-
disulfo-7-[(2-sulfophenyl)azo]-1-
naphthalenyl]amino]-1,3,5-
triazin-2-yl]amino]benzoic acid;
3,5-bis[[4-chloro-6-[[7-[(1,5-
disulfo-2-naphthalenyl)azo]-8-
hydroxy-3,6-disulfo-1-
naphthalenyl]amino]-1,3,5-
triazin-2-yl]amino]benzoic acid
435-440-6Eye Dam. 1H318GHS05
Dgr
H318   
611-169-00-0sodium 5-(2-carboxy-
phenylazo)-6-hydroxy-
naphthalene-2-sulfonate
435-800-2Aquatic Chronic 3H412H412   
611-170-00-6reaction mass of: trisodium 2-((1-(2-hydroxy-κ-O-5-
(2-sulfonatoethansulfonyl)phe-
nylazo-κ-N2)-1-phenyl-
methyl)azo-κ-N1)-4-
sulfonatobenzoate(5-)-κ-
O)cuprate(II);
disodium 2-((1-(5-ethene-
sulfonyl-2-hydroxy-κ-O-
phenylazo-κ-N2)-1-
phenylmethyl)azo-κ-N1)-
4-sulfonatobenzoate-κ-O-
(5-))cuprate(II)
435-880-9Aquatic Chronic 3H412H412   
611-171-00-1reaction mass of: trisodium
3-(5-(2,6-difluoropyrimidin-4-
ylamino)-2-sulfonatophenyl-
azo)-5-(4-fluoro-6-
morpholin-4-yl-1,3,5-triazin-2-
ylamino)-4-hydroxy-2,7-
naphthalenedisulfonate;
trisodium 3-(5-(4,6-
difluoropyrimidin-2-ylamino)-2-
sulfonatophenylazo)-5-(4-
fluoro-6-morpholin-4-yl-1,3,5-
triazin-2-ylamino)-4-hydroxy-
2,7-naphthalenedisulfonate
436-890-6Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
611-172-00-7reaction mass of: triammonium
6-amino-3-((2,5-diethoxy-4-
(3-phosphonophenyl)azo)
phenyl)azo-4-hydroxy-2-
naphthalenesulfonate;
diammonium 3-((4-((7-amino-1-
hydroxy-3-sulfo-naphthalen-2-yl)
azo)-2,5-diethoxyphenyl)
azo)benzoate
438-310-7Self-react. C****
Repr. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3
H242
H361f ***
H302
H373 **
H412
GHS02
GHS08
GHS07
Dgr
H242
H361f ***
H302
H373 **
H412
   
611-173-00-2reaction mass of:
3-[3-carbamoyl-5-(5-{4-chloro-
6-[4-(2-sulfonatooxyethyl-
sulfonyl)anilino]-1,3,5-triazin-2-
ylamino}-2-sulfonatophenyl-
azo)-1,2-dihydro-6-
hydroxy-4-methyl-2-oxo-1-
pyridyl]propanoic acid, trisodium salt;
3-[3-carbamoyl-5-(5-{4-chloro-
6-[4-(vinylsulfonyl)anilino]-
1,3,5-triazin-2-ylamino}-2-
sulfonatophenylazo)-
1,2-dihydro-6-hydroxy-4-
methyl-2-oxo-1-pyridyl]pro-
panoic acid,
disodium salt
440-510-4Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
611-174-00-8reaction mass of: 3-[5-(4-
ethenesulfonylbutyrylamino)-2-
sulfophenylazo]-5-{4-chloro-[6-
(4-(3-amino-5-hydroxy-2,7-
disulfonaphthalene-4-ylazo)-3-
sulfophenylamino]-1,3,5-
triazin-2-ylamino}-4-hydroxy-
naphthalene-2,7-
disulfonic acid, sodium salt;
3-[5-(4-(2-chloroethanesulfo-
nyl)butyrylamino)-
2-sulfophenylazo]-5-{4-chloro-
[6-(4-(3-amino-5-hydroxy-2,7-
disulfonaphthalene-4-ylazo)-3-
sulfophenylamino]-1,3,5-
triazin-2-ylamino}-4-hydroxy-
naphthalene-2,7-
disulfonic acid, sodium salt
442-290-5457624-86-1Eye Dam. 1H318GHS05
Dgr
H318   
611-175-00-3reaction mass of: trisodium
5-{4-chloro-6-[N-ethyl-(3-(2-
sulfonatooxy)ethylsulfo-
nyl)anilino]-1,3,5-triazin-2-
ylamino}-4-hydroxy-3-[4-
(vinylsulfonyl)phenylazo]naph-
thalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-
[N-ethyl-3-(vinylsulfonyl)ani-
lino]-1,3,5-triazin-
2-ylamino}-4-hydroxy-3-[4-(2-
(sulfonatooxy)ethylsulfonyl)
phenylazo]naphthalene-2,7-
disulfonate;
disodium 5-{4-chloro-6-
[N-ethyl-3-(vinylsulfonyl)ani-
lino]-1,3,5-triazin-2-ylamino}-
4-hydroxy-3-[(4-vinylsulfo-
nyl)phenylazo]naphthalene-
2,7-disulfonate;
tetrasodium 5-{4-chloro-6-
[N-ethyl-3-(2-(sulfonato-
oxy)ethylsulfonyl)anilino]-
1,3,5-triazin-2-ylamino}-3-[4-(2-
(sulfonatooxy)ethylsulfonyl)
phenylazo]-4-hydroxynaphthalene-2,7-disulfonate
444-050-5Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
611-176-00-92,6-bis(2,3,4-trihydroxy-
benzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-
naphthalenesulfonate
444-250-2Self-react. C****
Aquatic Chronic 2
H242
H411
GHS02
GHS09
Dgr
H242
H411
   
611-177-00-4reaction mass of: pentasodium bis[6-anilino-3,5´-disulfonato-
naphthalene-2-azobenzene-
1,2´-diolato]cobaltate(III);
tetrasodium [6-anilino-3,5´-
disulfonatonaphthalene-2-
azobenzene-1,2´-diolato][6-
anilino-5´-sulfamoyl-3-
sulfonatonaphthalene-2-
azobenzene-
1,2´-diolato]cobaltate(III);
trisodium bis[6-anilino-5´-sulfamoyl-
3-sulfonatonaphthalene-2-
azobenzene-1,2´-diolato]co-
baltate(III)
444-290-0508202-43-5Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
611-178-00-Xreaction mass of: pentasodium
4-amino-5-hydroxy-3-{(E)-4-[2-
(sulfonatooxy)ethylsulfonyl]
phenylazo}-6-{(E)-2-sulfonato-
4-[2-(sulfonatooxy)ethylsulfonyl]
phenylazo}naphthalene-2,7-
disulfonate;
tetrasodium 4-amino-5-
hydroxy-3-{(E)-4-[2-(sulfonato-
oxy)ethylsulfonyl]phenylazo}-
6-[(E)-2-sulfonato-4-(vinylsulfo-
nyl)phenylazo]naphthalene-
2,7-disulfonate;
tetrasodium 4-amino-5-
hydroxy-6-[(E)-2-sulfonato-
4-[2-(sulfonatooxy)ethylsul-
fonyl]phenylazo}-3-[(E)-4-
(vinylsulfonyl)phenylazo]
naphthalene-2,7-disulfonate;
trisodium 4-amino-5-
hydroxy-3-[(E)-4-(vinyl-
sulfonyl)phenylazo]-6-[(E)-
2-sulfonato-4-
(vinylsulfonyl)phenylazo]
naphthalene-2,7-disulfonate;
trisodium 4-amino-5-
hydroxy-3-[(2-hydroxy-
ethylsulfonyl)-phenylazo]-6-
[(E)-2-sulfonato-4-
(vinylsulfonyl)phenylazo]
naphthalene-2,7-disulfonate;
trisodium 4-amino-5-
hydroxy-3-[(E)-4-(vinyl-
sulfonyl)phenylazo]-6-[-2-
sulfonato-4-(2-hydroxyethyl-
sulfonyl)phenylazo]naph-
thalene-2,7-disulfonate
445-280-9Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
611-179-00-5reaction mass of: pentasodium
2-[[8-[[4-chloro-6-[[4-(2-sulfonato
ethylsulfonyl)]phenyl]amino]-
1,3,5-triazin-2-yl]amino-1-
hydroxy-3,6-disulfonato-2-
naphthalenyl]azo]naphthalene-
1,5-disulfonate;
2-[[8-[[4-chloro-6-[[4-[[2-
ethenyl]sulfonyl]phenyl]amino]-
1,3,5-triazin-2-yl]amino]-1-
hydroxy-3,6-disulfonato-2-
naphthalenyl]azo]naphthalene-
1,5-disulfonate
450-010-8Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
611-180-00-0iron, complexes with diazotised
4-aminobenzenesulfonamide, diazotised 3-aminoben-
zenesulfonic acid,
diazotised 3-amino-4-
hydroxybenzenesulfon-
amide, diazotised 3-amino-4-hydroxy-N-
phenylbenzenesulfonamide,
diazotised 5-amino-2-
(phenylamino)benzene-
sulfonic acid
and resorcinol, sodium salts
417-850-7Aquatic Chronic 2H411GHS09H411   
612-001-00-9mono-methylamine; [1]
di-methylamine; [2]
tri-methylamine [3]
200-820-0 [1]
204-697-4 [2]
200-875-0 [3]
74-89-5 [1]
124-40-3 [2]
75-50-3 [3]
Flam. Gas 1
Press. Gas
Acute Tox. 4 (*)
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
H220
H332
H335
H315
H318
GHS02
GHS04
GHS05
GHS07
Dgr
H220
H332
H335
H315
H318
 (*)
Skin Irrit. 2;
H315: C ≥ 5 %
Eye Dam. 1;
H318: C ≥ 5 %
Eye Irrit. 2; H319:
0,5 % ≤ C < 5 %
STOT SE 3;
H335: C ≥ 5 %
U 5
612-001-01-6mono-methylamine ...%; [1]
di-methylamine ...%; [2]
tri-methylamine ...% [3]
200-820-0 [1]
204-697-4 [2]
200-875-0 [3]
74-89-5 [1]
124-40-3 [2]
75-50-3 [3]
Flam. Liq. 1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
H224
H332
H302
H314
GHS02
GHS05
GHS07
Dgr
H224
H332
H302
H314
 (*)
STOT SE 3;
H335: C ≥ 5 %
B
612-002-00-4ethylamine200-834-775-04-7Flam. Gas 1
Press. Gas
Eye Irrit. 2
STOT SE 3
H220
H319
H335
GHS02
GHS04
GHS07
Dgr
H220
H319
H335
  U
612-003-00-Xdiethylamine203-716-3109-89-7Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A
H225
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H312
H302
H314
 STOT SE 3;
H335: C ≥ 1 %
 
612-004-00-5triethylamine204-469-4121-44-8Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A
H225
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H312
H302
H314
 STOT SE 3;
H335: C ≥ 1 %
 
612-005-00-0butylamine203-699-2109-73-9Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A
H225
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H312
H302
H314
 STOT SE 3;
H335: C ≥ 1 %
 
612-006-00-6ethylenediamine;
1,2-diaminoethane
203-468-6107-15-3Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H226
H312
H302
H314
H334
H317
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H312
H302
H314
H334
H317
   
612-007-00-12-aminopropane;
isopropylamine
200-860-975-31-0Flam. Liq. 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H224
H319
H335
H315
GHS02
GHS07
Dgr
H224
H319
H335
H315
   
612-008-00-7aniline200-539-362-53-3Carc. 2
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H351
H341
H331
H311
H301
H372 (*)(*)
H318
H317
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H351
H341
H331
H311
H301
H372 (*)(*)
H318
H317
H400
 (*)
STOT RE 1;
H372: C ≥ 1 %
STOT RE 2;
H373: 0,2 % ≤ C < 1%
 
612-009-00-2salts of anilineCarc. 2
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H351
H341
H331
H311
H301
H372 (*)(*)
H318
H317
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H351
H341
H331
H311
H301
H372 (*)(*)
H318
H317
H400
 (*)
STOT RE 1;
H372: C ≥ 1 %
STOT RE 2;
H373: 0,2 % ≤ C < 1%
A
612-010-00-8chloroanilines (with exception of those specified elsewhere in this Annex)Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 (*)(*)
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 (*)(*)
H410
  C
612-011-00-34-nitrosoaniline211-535-6659-49-4Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H332
H312
H302
GHS07
Wng
H332
H312
H302
   
612-012-00-9o-nitroaniline; [1]
m-nitroaniline; [2]
p-nitroaniline [3]
201-855-4 [1]
202-729-1 [2]
202-810-1 [3]
88-74-4 [1]
99-09-2 [2]
100-01-6 [3]
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 3
H331
H311
H301
H373 (*)(*)
H412
GHS06
GHS08
Dgr
H331
H311
H301
H373 (*)(*)
H412
  C
612-013-00-43-aminobenzene sulphonic acid;
metanilic acid
204-473-6121-47-1Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H332
H312
H302
GHS07
Wng
H332
H312
H302
   
612-014-00-Xsulphanilic acid;
4-aminobenzenesulphonic acid
204-482-5121-57-3Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
   
612-015-00-5N-methylaniline202-870-9100-61-8Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 (*)(*)
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 (*)(*)
H410
   
612-016-00-0N,N-dimethylaniline204-493-5121-69-7Carc. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Chronic 2
H351
H331
H311
H301
H411
GHS06
GHS08
GHS09
Dgr
H351
H331
H311
H301
H411
   
612-017-00-6N-methyl-N-2,4,6-tetranitro-
aniline;
tetryl
207-531-9479-45-8Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2
H201
H331
H311
H301
H373 **
GHS01
GHS06
GHS08
Dgr
H201
H331
H311
H301
H373 **
   
612-018-00-1bis(2,4,6-trinitrophenyl)amine;
hexyl
205-037-8131-73-7Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
Aquatic Chronic 2
H201
H330
H310
H300
H373 **
H411
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H330
H310
H300
H373 **
H411
   
612-019-00-7dipicrylamine, ammonium salt220-639-02844-92-0Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
Aquatic Chronic 2
H201
H330
H310
H300
H373 **
H411
GHS01
GHS06
GHS08
GHS09
Dgr
H201
H330
H310
H300
H373 **
H411
   
612-020-00-21-naphthylamine205-138-7134-32-7Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
612-022-00-32-naphthylamine202-080-491-59-8Carc. 1A
Acute Tox. 4 (*)
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411
 Carc. 1A; H350:
C ≥ 0,01 %
 
612-023-00-9phenylhydrazine; [1]
phenylhydrazinium chloride; [2]
phenylhydrazine hydrochloride; [3]
phenylhydrazinium sulphate (2:1) [4]
202-873-5 [1]
200-444-7 [2]
248-259-0 [3]
257-622-2 [4]
100-63-0 [1]
59-88-1 [2]
27140-08-5 [3]
52033-74-6 [4]
Carc. 1B
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H350
H341
H331
H311
H301
H372 (*)(*)
H319
H315
H317
H400
GHS06
GHS08
GHS09
Dgr
H350
H341
H331
H311
H301
H372 (*)(*)
H319
H315
H317
H400
   
612-024-00-4m-toluidine;
3-aminotoluene
203-583-1108-44-1Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
H331
H311
H301
H373 (*)(*)
H400
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 (*)(*)
H400
   
612-025-00-Xnitrotoluidines, with the exception of those specified elsewhere in this AnnexAcute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2
H331
H311
H301
H373 (*)(*)
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 (*)(*)
H411
  C
612-026-00-5diphenylamine204-539-4122-39-4Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 (*)(*)
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 (*)(*)
H410
   
612-027-00-0xylidines with the exception of those specified elsewhere in this Annex;
dimethyl anilines with the exception of those specified elsewhere in this Annex
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2
H331
H311
H301
H373 (*)(*)
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 (*)(*)
H411
  C
612-028-00-6p-phenylenediamine203-404-7106-50-3Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H319
H317
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H319
H317
H410
   
612-029-00-1benzene-1,4-diamine dihydrochloride;
p-phenylenediamine dihydrochloride
210-834-9624-18-0Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H319
H317
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H319
H317
H410
   
612-030-00-72-methyl-p-phenylenediamine sulphate [1]210-431-8 [1]
228-871-4 [2]
615-50-9 [1]
6369-59-1 [2]
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2
H301
H332
H312
H317
H411
GHS06
GHS09
Dgr
H301
H332
H312
H317
H411
   
612-031-00-2N,N-dimethylbenzene-1,3-
diamine; [1]
4-amino-N,N-dimethylaniline;
3-amino-N,N'-dimethylaniline [2]
220-623-3 [1]
202-807-5 [2]
2836-04-6 [1]
99-98-9 [2]
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
H331
H311
H301
GHS06
Dgr
H331
H311
H301
  C
612-032-00-8N,N,N',N'-tetramethyl-p-phenylenediamine202-831-6100-22-1Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H332
H312
H302
GHS07
Wng
H332
H312
H302
   
612-033-00-32-aminophenol202-431-195-55-6Muta. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H341
H332
H302
GHS08
GHS07
Wng
H341
H332
H302
   
612-034-00-92-amino-4,6-dinitrophenol;
picramic acid
N,N´-diacetylbenzidine
202-544-696-91-3Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3
H201
H332
H312
H302
H412
GHS01
GHS07
Dgr
H201
H332
H312
H302
H412
   
612-034-01-62-amino-4,6-dinitrophenol;
picramic acid;
[≥ 20 % water]
202-544-696-91-3Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Chronic 3
H332
H312
H302
H412
GHS07
Wng
H332
H312
H302
H412
  G
612-035-00-42-methoxyaniline;
o-anisidine
201-963-190-04-0Carc. 1B
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
H350
H341
H331
H311
H301
GHS06
GHS08
Dgr
H350
H341
H331
H311
H301
   
612-036-00-X3,3'-dimethoxybenzidine;
o-dianisidine
204-355-4119-90-4Carc. 1B
Acute Tox. 4 (*)
H350
H302
GHS08
GHS07
Dgr
H350
H302
   
612-037-00-5salts of 3,3'-dimethoxybenzidine;
salts of o-dianisidine
Carc. 1B
Acute Tox. 4 (*)
H350
H302
GHS08
GHS07
Dgr
H350
H302
  A
612-038-00-02-nitro-p-anisidine;
4-methoxy-2-nitroaniline
202-547-296-96-8Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
STOT RE 2 (*)
Aquatic Chronic 3
H330
H310
H300
H373 (*)(*)
H412
GHS06
GHS08
Dgr
H330
H310
H300
H373 (*)(*)
H412
   
612-039-00-62-ethoxyaniline;
o-phenetidine
202-356-494-70-2Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
H331
H311
H301
H373 (*)(*)
GHS06
GHS08
Dgr
H331
H311
H301
H373 (*)(*)
   
612-040-00-12,4-dinitroaniline202-553-597-02-9Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
STOT RE 2 (*)
Aquatic Chronic 2
H330
H310
H300
H373 (*)(*)
H411
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 (*)(*)
H411
   
612-041-00-74,4'-bi-o-toluidine204-358-0119-93-7Carc. 1B
Acute Tox. 4 (*)
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411
   
612-042-00-2benzidine;
1,1'-biphenyl-4,4'-diamine;
4,4'-diaminobiphenyl;
biphenyl-4,4'-ylenediamine
202-199-192-87-5Carc. 1A
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H302
H410
 Carc. 1A; H350:
C ≥ 0,01 %
 
612-043-00-8N,N'-dimethylbenzidine2810-74-4Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H332
H312
H302
GHS07
Wng
H332
H312
H302
   
612-044-00-3N,N'-diacetylbenzidine210-338-2613-35-4Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H350
H341
H332
H312
H302
GHS08
GHS07
Dgr
H350
H341
H332
H312
H302
   
612-046-00-4allylamine203-463-9107-11-9Flam. Liq. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Chronic 2
H225
H331
H311
H301
H411
GHS02
GHS06
GHS09
Dgr
H225
H331
H311
H301
H411
   
612-047-00-Xbenzylamine202-854-1100-46-9Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
   
612-048-00-5dipropylamine205-565-9142-84-7Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A
H225
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dgr
H225
H332
H312
H302
H314
 STOT SE 3;
H335: C ≥ 1 %
 
612-049-00-0di-n-butylamine; [1]
di-sec-butylamine [2]
203-921-8 [1]
210-937-9 [2]
111-92-2 [1]
626-23-3 [2]
Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H226
H332
H312
H302
GHS02
GHS07
Wng
H226
H332
H312
H302
   
612-050-00-6cyclohexylamine203-629-0108-91-8Flam. Liq. 3
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
H226
H361f ***
H312
H302
H314
GHS02
GHS05
GHS08
GHS07
Dgr
H226
H361f ***
H312
H302
H314
   
612-051-00-14,4'-diaminodiphenylmethane;
4,4'-methylenedianiline
202-974-4101-77-9Carc. 1B
Muta. 2
STOT SE 1
STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 2
H350
H341
H370 (*)(*)
H373 (*)(*)
H317
H411
GHS08
GHS07
GHS09
Dgr
H350
H341
H370 (*)(*)
H373 (*)(*)
H317
H411